TREM2 and colorectal carcinoma: In a TCGA CRC cohort, TREM2 expression was associated with worse overall survival and correlated with immunosuppressive genes (i.e., MSR1, HAVCR2) and lipid metabolism genes (APOC1, APOE, OLR1) [38].